Ophthalmic Business News

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Sandor Palfi discusses ways that Johnson & Johnson Vision plans to continue to improve the lives of patients and surgeons.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Kevin J. Corcoran, COE, CPC, CPMA, FNAO, discusses ophthalmic economic and regulatory updates for the year.

KOLOA, Hawaii — Hypersensitivity reactions to injection fillers are rare and unpredictable, but when they occur, clinicians need to know how to manage them, a presenter here said.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Paul Smith of Orasis Pharmaceuticals discusses phase 3 data for the CSF-1 eye drop for presbyopia treatment following its new drug application submission to the FDA.

Keranova reported positive results for FemtoMatrix, its robotic laser technology used for PhotoEmulsification in cataract surgery.

Jim Mazzo will be honored with the second annual Lindstrom Leadership Award and Lecture for his career in the ophthalmic industry.

Glaukos reported positive results in a clinical trial investigating the safety of the surgical exchange procedure for the iDose TR in subjects who had previously received the implant in a phase 2b clinical trial.

Thirona, which specializes in artificial intelligence-assisted medical imaging, is spinning out its retina division, according to a press release.

As advisors to physicians throughout the U. S., we often learn what misconceptions physicians have regarding how to protect their assets from potential lawsuits. In this article, I hope to dispel some incorrect assumptions you may have.

VRDN-001 demonstrated positive results at a low dose for the treatment of active thyroid eye disease in a phase 1/2 clinical trial, according to a press release from Viridian Therapeutics.